Mesfin Gebremichael, MD | |
9801 Greenbelt Rd, Suite 101, Lanham, MD 20706-2273 | |
(301) 552-6666 | |
Not Available |
Full Name | Mesfin Gebremichael |
---|---|
Gender | Male |
Speciality | Critical Care (intensivists) |
Experience | 40 Years |
Location | 9801 Greenbelt Rd, Lanham, Maryland |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1609957430 | NPI | - | NPPES |
5894029 | Other | MD | AETNA |
73153 | Other | MD | AMERIGROUP |
2102082 | Other | MD | MAMSI |
G469 | Other | MD | CAREFIRST |
P00174253 | Other | MD | RAILROAD MEDICARE |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RP1001X | Internal Medicine - Pulmonary Disease | D0042354 (Maryland) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Doctors' Community Hospital | Lanham, MD | Hospital |
Adventist Healthcare White Oak Medical Center | Silver spring, MD | Hospital |
Umd Prince George's Hospital Ctr | Cheverly, MD | Hospital |
Entity Name | Greenbelt Medical Associates |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1710068549 PECOS PAC ID: 6204875461 Enrollment ID: O20050427000530 |
News Archive
Since the dietary guidelines are relying heavily on what we believe to be a flawed interpretation of the data by the IOM, our study is a very important analysis for the nutrition community as a whole, and particularly for nutrition policy," said Maureen Storey, director of the Center for Food and Nutrition Policy, who coauthored the study with Richard Forshee, research assistant professor at the CFNP.
SynCo Bio Partners, a Netherlands based biopharmaceutical contract manufacturer, and Versartis, Inc. today announced a strategic partnership to produce Versartis' lead drug candidate VRS-859, a novel GLP-1 analog for monthly dosing to treat type 2 diabetes Under the agreement, SynCo will further develop the Versartis existing production process for VRS-859 and optimize the manufacturing process to increase yields for the forthcoming cGMP production.
Providing clues to deafness, researchers at Washington University School of Medicine in St. Louis have identified a gene that is required for proper development of the mouse inner ear.
Prosonix, an innovative speciality pharmaceutical company developing a portfolio of inhaled Respiratory Medicines by Design, announces positive top-line results from its Phase 2 clinical study with PSX1002 in patients with moderate to severe chronic obstructive pulmonary disease.
Nearly half of Americans in their 50s and early 60s think they're likely to develop dementia as they grow older, but only 5% of them have actually talked with a doctor about what they could do to reduce their risk, a new study finds.
› Verified 1 days ago
Mailing Address | Practice Location Address |
---|---|
Mesfin Gebremichael, MD 203 Linton Knoll Ct, Silver Spring, MD 20904-1270 Ph: (301) 552-6666 | Mesfin Gebremichael, MD 9801 Greenbelt Rd, Suite 101, Lanham, MD 20706-2273 Ph: (301) 552-6666 |
News Archive
Since the dietary guidelines are relying heavily on what we believe to be a flawed interpretation of the data by the IOM, our study is a very important analysis for the nutrition community as a whole, and particularly for nutrition policy," said Maureen Storey, director of the Center for Food and Nutrition Policy, who coauthored the study with Richard Forshee, research assistant professor at the CFNP.
SynCo Bio Partners, a Netherlands based biopharmaceutical contract manufacturer, and Versartis, Inc. today announced a strategic partnership to produce Versartis' lead drug candidate VRS-859, a novel GLP-1 analog for monthly dosing to treat type 2 diabetes Under the agreement, SynCo will further develop the Versartis existing production process for VRS-859 and optimize the manufacturing process to increase yields for the forthcoming cGMP production.
Providing clues to deafness, researchers at Washington University School of Medicine in St. Louis have identified a gene that is required for proper development of the mouse inner ear.
Prosonix, an innovative speciality pharmaceutical company developing a portfolio of inhaled Respiratory Medicines by Design, announces positive top-line results from its Phase 2 clinical study with PSX1002 in patients with moderate to severe chronic obstructive pulmonary disease.
Nearly half of Americans in their 50s and early 60s think they're likely to develop dementia as they grow older, but only 5% of them have actually talked with a doctor about what they could do to reduce their risk, a new study finds.
› Verified 1 days ago
Dr. Hwaida Hannoush, M.D. Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 9831 Greenbelt Rd Ste 103, Lanham, MD 20706 Phone: 301-277-3555 Fax: 301-552-0098 | |
Dr. Farhan Ali Shah, MD Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 8118 Good Luck Rd, Lanham, MD 20706 Phone: 301-552-8118 | |
Maheteme Bayeh, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 9801 Greenbelt Rd, Suite 101, Lanham, MD 20706 Phone: 301-552-6666 Fax: 301-552-6216 | |
Dr. Rodney Lane Ellis, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 9811 Greenbelt Rd, Suite 104, Lanham, MD 20706 Phone: 301-552-3953 Fax: 301-552-3957 | |
Dr. Vineet Venugopal, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 8116 Good Luck Rd Ste 305, Lanham, MD 20706 Phone: 301-552-1200 Fax: 301-552-1202 | |
Dr. Vivek Bahl, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 8116 Good Luck Rd Ste 305, Lanham, MD 20706 Phone: 301-552-1200 Fax: 301-552-1202 | |
Ravjyot Chawla, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 8116 Good Luck Rd Ste 305, Lanham, MD 20706 Phone: 301-552-1200 Fax: 301-552-1202 |